menu search

MMSI / Merit Medical Caught Up In The Med-Tech Downswing

Merit Medical Caught Up In The Med-Tech Downswing
Merit Medical delivered another quarter ahead of expectations, with strong growth in peripheral intervention, OEM manufacturing, and endoscopy, driving 7% organic revenue growth coupled with opex leverage. Assets acquired from AngioDynamics are already outperforming initial expectations, and performance in several peripheral and cardiac markets suggests share gains. The pivotal study for the Wrapsody endovascular graft is complete and Merit should be in a position to launch the product before the end of 2024. Read More
Posted: Oct 31 2023, 20:07
Author Name: Seeking Alpha
Views: 091934

MMSI News  

Merit Medical Caught Up In The Med-Tech Downswing

By Seeking Alpha
October 31, 2023

Merit Medical Caught Up In The Med-Tech Downswing

Merit Medical delivered another quarter ahead of expectations, with strong growth in peripheral intervention, OEM manufacturing, and endoscopy, drivin more_horizontal

PDCO vs. MMSI: Which Stock Is the Better Value Option?

By Zacks Investment Research
October 31, 2023

PDCO vs. MMSI: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Patterson Cos. (PDCO) or Merit Medical (MMSI). more_horizontal

Merit Medical (MMSI) Q3 Earnings Top Estimates, FY23 View Revised

By Zacks Investment Research
October 27, 2023

Merit Medical (MMSI) Q3 Earnings Top Estimates, FY23 View Revised

Merit Medical (MMSI) benefits from revenue growth in both segments and all product categories within its Cardiovascular unit in the third quarter. more_horizontal

Merit Medical Systems, Inc. (MMSI) Q3 2023 Earnings Call Transcript

By Seeking Alpha
October 26, 2023

Merit Medical Systems, Inc. (MMSI) Q3 2023 Earnings Call Transcript

Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q3 2023 Earnings Conference Call October 26, 2023 5:00 PM ET Company Participants Fred Lampropoulos – Fou more_horizontal

Merit Medical (MMSI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

By Zacks Investment Research
October 26, 2023

Merit Medical (MMSI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Merit Medical (MMSI) give a sense of how its business performed in the quarter ended September 2023, it might be wort more_horizontal

Merit Medical (MMSI) Beats Q3 Earnings and Revenue Estimates

By Zacks Investment Research
October 26, 2023

Merit Medical (MMSI) Beats Q3 Earnings and Revenue Estimates

Merit Medical (MMSI) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.65 per share. This compares to ea more_horizontal

Merit Medical's (MMSI) New Launch to Expand Its Product Suite

By Zacks Investment Research
October 12, 2023

Merit Medical's (MMSI) New Launch to Expand Its Product Suite

Merit Medical's (MMSI) latest addition to its Vascular portfolio is expected to significantly improve patient outcomes. more_horizontal

3 Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio

By Zacks Investment Research
October 5, 2023

3 Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio

Merit Medical's (MMSI) strong product portfolio raises optimism about the stock. more_horizontal


Search within

Pages Search Results: